Intended for healthcare professionals

Research Article

Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone.

Br Med J 1979; 1 doi: (Published 09 June 1979) Cite this as: Br Med J 1979;1:1534

This article has a correction. Please see:

  1. R G Henderson,
  2. T Wheatley,
  3. J English,
  4. J Chakraborty,
  5. V Marks


    Renal transplant recipients receiving intermittent haemodialysis and kept under normal ward conditions showed appreciable differences in plasma prednisolone concentrations after therapeutic doses of enteric-coated prednisolone tablets. This gross day-to-day variation occurred irrespective of the dosage used. Breakfast given before prednisolone tended to reduce the rate of absorption of the drug, the effect being quantitatively most pronounced with large doses. Haemodialysis had no apparent effect on the elimination of prednisolone from plasma. Such erratic blood concentrations of prednisolone as observed in these patients, possibly resulting from variable absorption, may be potentially hazardous. Hence use of enteric-coated tablets in renal transplant recipients should be viewed with caution.